(Q44597096)

4 December 2017

title

Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension (English)

1 reference

4 December 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

14 March 2024

2

Thomas M. MacDonald

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510903

14 March 2024

Pitt O. Lim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510903

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14510903

14 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2265.2003.01841.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2265.2003.01841.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

14 March 2024

published in

Clinical Endocrinology

1 reference

4 December 2017

volume

59

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

427-430

1 reference

Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Selected major risk factors and global and regional burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

A review of the medical treatment of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Primary aldosteronism: revival of a syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Blood pressure screening, management and control in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Optimisation of antihypertensive treatment by crossover rotation of four major classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Awareness, treatment, and control of hypertension in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Cell cycle regulatory proteins in glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01841.X

Mineralocorticoid hypertension

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

Validity of the aldosterone-renin ratio used to screen for primary aldosteronism

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

The pathophysiology of aldosterone in the cardiovascular system

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

Primary aldosteronism: management issues

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01841.X

14 March 2024

Identifiers

1 reference

4 December 2017

1 reference